Danish feed giant BioMar continued to sail steadily through the ongoing COVID-19 pandemic in the third quarter, reporting a 4 percent increase in revenues driven by higher volume sales in its salmon division.
However, the group did see earnings before interest taxes, depreciation, and amortization (EBITDA) slip 6 percent to DKK 326 million (€43.8 million/$51.7 million) during the period, mainly due to unfavourable exchange rate developments.
